Sun Park
Executive VP & CFO at Tenet Healthcare
About one third of this increase is related to the second half of twenty twenty four and is expected to be recorded in the first quarter of this year. Finally, we would expect first quarter twenty twenty five consolidated adjusted EBITDA to be in the range of 24% to 25% of our full year consolidated EBITDA at the midpoint. We anticipate that USPI's EBITDA in the first quarter this year will be 21% to 22% of our full year USPI EBITDA at the midpoint. Turning to our cash flow for '25, we expect cash flow from operations in the range of $2,500,000,000 to $2,850,000,000 capital expenditures in the range of $700,000,000 to $800,000,000 resulting in free cash flows in the range of $1,800,000,000 to $2,050,000,000 In addition, we're also assuming distributions to NCI in the range of $750,000,000 to $800,000,000 which would result in free cash flow after NCI in the range of $1,050,000,000 to $1,250,000,000 And finally, as a reminder, our capital deployment priorities have not changed. First, we will continue to prioritize capital investments to grow USPI through M and A.